1. DIAGNOSTIC Testing
  1. Next Generation Sequencing and Copy Number Variation Analysis
    Turnaround time for next generation sequencing and deletion/duplication tests is 2 to 4 weeks following receipt of a sample in the laboratory.
  2. Sanger Sequencing
    Turnaround time for Sanger sequencing tests is 1 to 2 weeks following receipt of a sample in the laboratory.
...
...
2. CARRIER SCREENING
CTGT strives to complete all carrier screening tests within 2 weeks of receipt of a sample in the laboratory.
 

CTGT makes every effort to expedite cases involving ongoing pregnancies and cases with other special circumstances (for example, surgery or bone marrow transplant is dependent on the results). If a sample needs to be expedited, please indicate on the requisition form or contact us at (484) 244-2900 or secure email to Inquiries@ctgt.net. Please be reminded not to send patient information via unencrypted email as email is inherently unsecure

IMPORTANT:

While the above turnaround times are CTGT’s stated goal for completing all tests and CTGT meets these turnaround times in >90% of cases, we cannot guarantee that any individual test will be completed within these time frames.

The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. HNL Lab Medicine strongly recommends confirmation of CPT codes with third-party payors and/or the AMA. We assume no responsibility for billing errors due to reliance upon CPT codes provided by HNL Lab Medicine.

What's New

April 11, 2022

Genome Sequencing: A Vital Tool Used in Identifying and Tracking New COVID-19 Variants

Genome sequencing is reading or decoding the complete genetic information i.e. “Genome” of an organism that is encrypted in the form of a very long string called DNA made up of 4 letters, A, T, G, and C. The genome of an organism essentially determines their physical characteristics and ...
Read More
March 03, 2022

The Effect of Genetics on Individual Heart Health: Early Identification of FH Variations to Optimize Treatment

Test must be ordered by a Physician.

Familial hypercholesterolemia (FH) is a genetic disorder that is characterized by abnormally high blood levels of low-density lipoprotein (LDL) cholesterol, sometimes referred to as "bad cholesterol". This condition affects an estimated 1 in 250 people, and increases the likelihood of developing cardiovascular disease. In fact, FH is estimated to be the cause of 2-3% of heart attacks in individuals younger than age 60.

Read More
October 13, 2021

CTGT.net: A New Website Experience

We've refreshed our look and feel to better meet your needs. 

CTGT's new website is not only user-friendly but also provides more advanced test search capabilities, additional methodologies, and a clean design suited for multi-platform usage.

Read More
September 28, 2021

9 New Tests for Genetic Carrier Screening Panels

CTGT is now offering 9 NEW tests for Genetic Carrier Screening. 
Read More
September 25, 2021

New York State Clinical Laboratory Permit Approval

CTGT is proud to announce that its CLIA licensed and CAP-accredited Pennsylvania laboratory has earned a New York State Department of Health clinical laboratory permit to perform genetic testing for patients residing within the state of New York. 
Read More